About $14,581 carries one veteran through this phase — every gift is measured in lives, not just dollars.
- Participants
- 380 (400 total)
- Design
- Three-arm RCT, 1:1:1
- Arms
- CCJ / Brain / Combined
- Duration
- 18 months
- Imaging
- Full suite, all arms
- Total ask
- $20,069,695
Phase 3 is the study the entire program was built to make possible. It enrolls the remaining participants to reach four hundred veterans in total, randomized across three arms: one receiving structural care, one receiving brain-focused care, and one receiving both in coordinated sequence. This three-way comparison is what allows the study to answer the question definitively rather than suggestively — revealing not just whether these treatments work, but for whom, and which combination gives each veteran the best chance of real recovery.
Because Phase 2 already built and proved the operational machine, Phase 3 requires no startup period. Nearly every dollar flows straight to the front line: to the care itself and to the imaging that documents its effect. Four hundred veterans receive care within this study. The findings it produces could change care for hundreds of thousands more.
What it delivers
The definitive, adequately powered comparison of structural, brain-focused, and combined intervention — findings of sufficient rigor to withstand scrutiny at the highest levels of military medical leadership and to inform Department of Defense and Veterans Affairs policy on mTBI screening, diagnosis, and treatment.
Your support here coversThe direct treatment of hundreds of veterans across all three arms, the comprehensive imaging that gives the findings their scientific weight, the full assessment battery at every stage, the research leadership that holds an eighteen-month trial to the highest standard, added treatment capacity, and travel support so no veteran is turned away by distance.
Last updated August 15, 2026